Dako, Lilly to collaborate, 3/13:76Master Framework Agreement • December 25th, 2022
Dako, an Agilent Technologies company, has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investigational oncology medicine currently under development by Lilly.
Dako, Lilly to collaborate, 3/13:76Master Framework Agreement • October 28th, 2021
Dako, an Agilent Technologies company, has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investigational oncology medicine currently under development by Lilly.